Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2023

Mar 9, 2023

31996_dirs_2023-03-08_d2750e4f-fd06-4bec-adce-2f1ced196e2f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2023-03-07

Reporting Person: Barnes Scott D (Chief Medical Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-03-07 Common Stock F 777 $58.13 Disposed 30540 Direct
2023-03-07 Common Stock M 1603 $58.13 Acquired 32143 Direct

Footnotes

F1: Performance Stock Units (PSUs) converted into common shares on a one-to-one basis, with the amount representing the vesting of PSUs awarded on March 7, 2022, with achievement based on the Corporation's satisfaction of pre-established financial metrics.